NTRK1 and cancer: Given the intricate and extensive network of disulfide bonding in these receptors that is critical for their proper folding and function, we hypothesized that compounds able to disrupt disulfide bonds might preferentially inactivate HER-family receptor tyrosine kinases and that this might explain the pattern of cancer cell line responsiveness to these agents.